Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity. The blockbuster drug could be manufactured for 89 cents to…#novonordiskas #yaleuniversity #kingscollegehospital #novo #ozempicandwegovy #catalentinc #medicare #berniesanders #vermont #novonordisk
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | Medicare | Obesity | Study